secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viatris Inc (VTRS)
CIK:        0001792044
Form:       8-K
Filed at:   2022-08-08T23:59:59+00:00
Accession:  0001792044-22-000026
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viatris Q2 2022: Revenue $4.12B, adj. EBITDA $1.48B, reaffirms guidance
-----------------------------------------------------------------------

- Total revenues $4.12B; U.S. GAAP net earnings $314M; adjusted EBITDA $1.48B.
- Free cash flow $719M in Q2; H1 free cash flow ~$1.8B.
- Reaffirms adjusted EBITDA and free cash flow guidance; revises total revenue guidance for FX.
- Declares quarterly dividend $0.12 per share; paid down ~$1.5B debt in H1, on track for $2B full year.
- Biocon Biologics transaction on track for H2 2022 close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792044/000179204422000026/0001792044-22-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792044/000179204422000026/vtrs-20220808.htm
  HTML page:      https://secwatch.observer/filing/0001792044-22-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer